Day: April 30, 2022

Apr 30
U.S. inflation rate surges to 6.6%, PCE index shows, but prices might also be peaking

The numbers: The Federal Reserve’s preferred measure of inflation rose a sharp 0.9% in March, but the increase largely stemmed from a surge in the cost of gas and there were some signs that intense price pressures could be starting to ease. Over the past 12 months, the personal consumption price index has climbed 6.6%, […]

Apr 30
AbbVie’s stock is down 3% after missing on revenue in the first quarter of 2022

An earlier version of this report incorrectly listed Rinvoq’s revenue. The drug generated $465 million in revenue in the first quarter of 2022. Shares of AbbVie Inc. ABBV, -6.03% were down 3.4% in premarket trading on Friday after the company missed on revenue in the first quarter of the year. AbbVie had earnings of $4.5 […]

Apr 30
Daily Market Outlook, April 29, 2022

Daily Market Outlook, April 29, 2022 Overnight Headlines China And U.S. Negotiate On-Site Audit Checks As Delistings Loom RBA To Raise Rates To 0.25% On Tuesday, To End Year At 1.50% – RTRS Poll More UK Companies See Price Increases Even As Economy Slows Dollar Towers At Two-Decade High On Growth Woes, Fed Outlook Goldman […]

Apr 30
Stocks open lower, on track for worst month since March 2020

Stocks opened lower Friday, weighed down as shares of Amazon.com Inc. AMZN, -14.05% and Apple Inc. AAPL, -3.66% lost ground after quarterly updates. The Dow Jones Industrial Average DJIA, -2.77% fell 90 points, or 0.3%, at 33,826,leaving it on track for a 2.5% monthly fall. The S&P 500 SPX, -3.63% was down 0.7% at 4,256, […]

Apr 30
Bitcoin halving analysis hints at $24K bottom before the end of 2022

One of the most popular topics of debate within the crypto community revolves around the Bitcoin (BTC) four-year halving cycle and the effect it has on the long-term price of the top cryptocurrency.  Bitcoin price failed to hit the long-predicted $100,000 level in 2021 and many crypto analysts now find themselves wondering about the outlook […]

Apr 30
FDA advisory committee to review Novavax’s COVID-19 vaccine candidate in June

Shares of Novavax Inc. NVAX, +1.81% jumped 10.8% in trading on Friday after the Food and Drug Administration announced that an advisory committee is set to meet June 7 to examine the benefits and risks of the company’s experimental COVID-19 vaccine. Novavax’s protein-based vaccine has been authorized in several countries, including by the U.K. and […]